
Good, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Telephone (202) 307-7297.ĭue to concerns regarding possible harmful side effects, the Food and Drug Administration (FDA) initiated action in November 2000, to remove phenylpropanolamine (PPA) from the market and requested that all drug companies discontinue marketing products containing PPA. DEA will not accept any file format other than those specifically listed here.įOR FURTHER INFORMATION CONTACT: Patricia M. DEA will accept electronic comments containing MS Word, WordPerfect, Adobe PDF, or Excel files only. An electronic copy of this document is also available at the website. Comments may be directly sent to DEA electronically by sending an electronic message to Comments may also be sent electronically through using the electronic comment form provided on that site. Written comments sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/CCD, 2401 Jefferson-Davis Highway, Alexandria, VA 22301. Written comments being sent via regular mail should be sent to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative/CCD. DEA-211P" on all written and electronic correspondence. DEA is soliciting the chemical industry for comments to describe alternate security systems that are equal to the existing controlled substances schedule III through V system.ĭATES: To allow adequate time for industry to identify alternative security solutions, written comments must be postmarked, and electronic comments must be sent, on or before October 28, 2004.ĪDDRESSES: To ensure proper handling of comments, please reference "Docket No. These measures will limit the opportunity for theft and diversion of these chemicals. Based on the number of reports and the size of thefts from manufacturers and distributors of these chemicals, DEA is proposing that these companies implement security measures similar to or as effective as those used for schedule III through V controlled substances.


These chemicals are available in over-the-counter medications and are widely used in the illicit production of methamphetamine and amphetamine. SUMMARY: DEA is proposing to require that manufacturers, distributors, importers, and exporters of pseudoephedrine, ephedrine, and phenylpropanolamine (PPA) implement security procedures to prevent the theft and diversion of these List I chemicals. Security Requirements for Handlers of Pseudoephedrine, Ephedrine, and PhenylpropanolamineĪGENCY: Drug Enforcement Administration (DEA), Justice.

FR Doc 04-17356 From the Federal Register Online via GPO Access
